Skystar Bio-Pharmaceutica announced that China's Ministry of Agriculture, or MOA, Good Manufacturing Process "GMP" experts have physically inspected Skystar's Huxian veterinary drug manufacturing plant and has published its recommendation to renew Skystar's GMP certificate which is valid for a period of five years.
Asian shares tumbled to nine-month lows on Thursday as slowing Chinese manufacturing activity exacerbated sentiment …